Vanguard Group Inc Context Therapeutics Inc. Call Options Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CNTX
# of Institutions
37Shares Held
57.2MCall Options Held
0Put Options Held
0-
Deep Track Capital, LP Greenwich, CT7.42MShares$17.2 Million0.49% of portfolio
-
Great Point Partners LLC Greenwich, CT7.42MShares$17.2 Million3.93% of portfolio
-
Nextech Invest Ag7.42MShares$17.2 Million2.8% of portfolio
-
Avidity Partners Management LP Dallas, TX7.42MShares$17.2 Million0.73% of portfolio
-
Blue Owl Capital Holdings LP New York, NY5.16MShares$12 Million4.29% of portfolio
About Context Therapeutics Inc.
- Ticker CNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,966,100
- Market Cap $37M
- Description
- Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...